Correlation Engine 2.0
Clear Search sequence regions


  • 3 utr (1)
  • BRD4 (3)
  • c myc (1)
  • case report (1)
  • CK19 (1)
  • diagnosis (2)
  • exon (1)
  • gene fusions (3)
  • gene report (1)
  • IGKV (2)
  • keratosis (1)
  • nuclear protein (1)
  • pathogenesis (2)
  • patient (1)
  • PD L1 (2)
  • testis (1)
  • thyroid (4)
  • TTF 1 (1)
  • Sizes of these terms reflect their relevance to your search.

    Nuclear protein in testis (NUT) carcinoma (NC) is a rare and aggressive undifferentiated carcinoma that typically arises from midline supradiaphragmatic structures. It is uniquely driven by a NUT gene rearrangement on chromosome 15q14. Few thyroid NCs have been reported and there are no established treatment guidelines for NUT carcinoma. Ultrasound-guided fine needle aspiration smear was performed for the preoperative diagnosis of thyroid lesions. Cytopathology, histology, and immunochemical staining all indicated NC. Fluorescence in situ hybridization (FISH), qRT-PCR, and next-generation sequencing (NGS) were used to analyze the genetic characteristics of NC. We describe a rare case of thyrogenic NC in a 38-year-old male with cytological, histological, immunohistochemical, and genetic features. Cytological smears and histopathological specimens showed typical features of NC. Immunohistochemistry confirmed strong immunoreactivity with NUT, EMA, P63, TTF-1, and c-myc. CK19 was positive exclusively in sudden keratosis. No immunoreactivity was found for neuroendocrine markers. FISH was applied to isolate the NUT gene on chromosome 15q14. The NGS results revealed a BRD4-NUT gene fusion, which was further confirmed by RT-qPCR. Structural variation (SV) of NUTM1 occurred in the exon region, and the mutation site was 15q14. Moreover, BRD4 single-nucleotide variation (SNV) occurs in the 3' UTR at mutation site 19p13.12. The PD-L1 combined predictive score was over 30%. The patient received chemotherapy, followed by programmed cell death 1 (PD-1) inhibition with camrelizumab, and died 10 months after surgery. Thyroid NC is an extremely rare and fatal malignant tumor. It is necessary to consider NC when squamous differentiation is observed cytologically or histologically. NGS is an effective tool for obtaining the final diagnosis and obtaining a better understanding of tumor pathogenesis. A large number of IGKV gene fusions in addition to the BRD4-NUT fusion may play a role in the pathogenesis and immunotherapy response of NC. Immunotherapy for NC remains to be explored due to the rarity of this aggressive malignancy. Copyright © 2022 Zhou, Duan, Jiao, Chen, Xing, Su, Tang, Zhang and Liu.

    Citation

    Juan Zhou, Miao Duan, Qiong Jiao, Chunyan Chen, Aiyan Xing, Peng Su, Juan Tang, Hui Zhang, Zhiyan Liu. Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive IGKV Gene Fusions: A Case Report With Treatment Implications and Literature Review. Frontiers in oncology. 2021;11:778296


    PMID: 35127482

    View Full Text